Literature DB >> 21365319

Toenail onychomycosis in a Portuguese geriatric population.

N Dias1, C Santos, M Portela, N Lima.   

Abstract

Onychomycosis is a common fungal infection of the nail but few data of mycological features in geriatric Portuguese population are yet available. The aim of this study was to perform a mycological examination and characterization of fungal nail pattern of a geriatric population from the north of Portugal clinically suspected of onychomycosis. A total of 108 patients attending the Podology Service in the Centro Hospitalar do Alto Ave (Portugal) from October 2007 to January 2009 were enrolled. All were suspected of having onychomycosis by the abnormal appearance of their nails. From these, 59.3% were diabetic. Distal and lateral subungual onychomycosis was the more common clinical pattern followed by total dystrophic onychomycosis. In 21.3% cases, every nail in both feet had an abnormal appearance. In 86%, the hallux was involved in at least one foot. Fifty samples were culture positive, and fifty-four isolates were reported regardless of the questionable pathogenicity of the infectious agent. In three cases, clinical feature of the nail, direct microscopy, and culture were consistent with Scopulariopsis infection. Fusarium spp. were identified in three cases; however, only one isolate was preceded by the observation of branching septate filaments by direct microscopy. No mixed infections with dermatophytes were reported. Trichophyton rubrum was the dermatophyte most frequently isolated (83.3%) followed by Trichophyton interdigitale. In Portugal, onychomycosis is still viewed by general population as a cosmetic condition. Health risk is enhanced in geriatrics that only perceived the severity of their condition when experiencing further foot complications that include bacterial infection and pain.

Entities:  

Mesh:

Year:  2011        PMID: 21365319     DOI: 10.1007/s11046-011-9402-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  29 in total

Review 1.  Clinical practice. Fungal nail disease.

Authors:  David de Berker
Journal:  N Engl J Med       Date:  2009-05-14       Impact factor: 91.245

2.  Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes.

Authors:  Richard C Summerbell; Elizabeth Cooper; Ursula Bunn; Frances Jamieson; Aditya K Gupta
Journal:  Med Mycol       Date:  2005-02       Impact factor: 4.076

Review 3.  Conventional methods for the diagnosis of dermatophytosis.

Authors:  Raymond Robert; Marc Pihet
Journal:  Mycopathologia       Date:  2008-05-14       Impact factor: 2.574

4.  Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients.

Authors:  Jacek C Szepietowski; Adam Reich; Emilia Garlowska; Marzena Kulig; Eugeniusz Baran
Journal:  Arch Dermatol       Date:  2006-10

5.  Effect of onychomycosis on quality of life.

Authors:  L A Drake; R K Scher; E B Smith; G A Faich; S L Smith; J J Hong; M J Stiller
Journal:  J Am Acad Dermatol       Date:  1998-05       Impact factor: 11.527

6.  Prevalence of toe nail onychomycosis in diabetic patients.

Authors:  Ditte Marie L Saunte; Jane B Holgersen; Merete Haedersdal; Gitte Strauss; Mikael Bitsch; Ole L Svendsen; Maiken C Arendrup; Else L Svejgaard
Journal:  Acta Derm Venereol       Date:  2006       Impact factor: 4.437

Review 7.  New diagnostic techniques.

Authors:  M Feuilhade de Chauvin
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-09       Impact factor: 6.166

8.  Patients at risk of onychomycosis--risk factor identification and active prevention.

Authors:  A Tosti; R Hay; R Arenas-Guzmán
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-09       Impact factor: 6.166

9.  Onychomycosis.

Authors:  C Seebacher; J Brasch; D Abeck; O Cornely; I Effendy; G Ginter-Hanselmayer; N Haake; G Hamm; U-Ch Hipler; H Hof; H C Korting; P Mayser; M Ruhnke; K-H Schlacke; H-J Tietz
Journal:  Mycoses       Date:  2007-07       Impact factor: 4.377

Review 10.  Toenail onychomycosis in diabetic patients: issues and management.

Authors:  Peter Mayser; Viviane Freund; Debby Budihardja
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

View more
  6 in total

1.  New Insights for Diagnosis of Pineapple Fusariosis by MALDI-TOF MS Technique.

Authors:  Cledir Santos; José Aires Ventura; Nelson Lima
Journal:  Curr Microbiol       Date:  2016-04-27       Impact factor: 2.188

2.  Tazarotene as alternative topical treatment for onychomycosis.

Authors:  Elena Campione; Evelin Jasmine Paternò; Gaetana Costanza; Laura Diluvio; Isabella Carboni; Daniele Marino; Cartesio Favalli; Sergio Chimenti; Luca Bianchi; Augusto Orlandi
Journal:  Drug Des Devel Ther       Date:  2015-02-16       Impact factor: 4.162

3.  Clinico-mycological study of dermatophyte toenail onychomycosis in new delhi, India.

Authors:  Pravesh Yadav; Archana Singal; Deepika Pandhi; Shukla Das
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

4.  Onychomycosis in patients with chronic leg ulcer and toenail abnormalities.

Authors:  Joana Cabete; Célia Galhardas; Margarida Apetato; Sara Lestre
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

5.  Polyphasic Approach Including MALDI-TOF MS/MS Analysis for Identification and Characterisation of Fusarium verticillioides in Brazilian Corn Kernels.

Authors:  Susane Chang; Mariele Porto Carneiro-Leão; Benny Ferreira de Oliveira; Cristina Souza-Motta; Nelson Lima; Cledir Santos; Neiva Tinti de Oliveira
Journal:  Toxins (Basel)       Date:  2016-02-24       Impact factor: 4.546

6.  Translation and Cross-Cultural Adaptation of Quality of Life Scale in Patients with Onychomycosis.

Authors:  Vasco Silva-Neves; Ana Caramelo; Paulo Alves; Carla Pais-Vieira; Alexandra Palmer Minton; Ana María Rodríguez-Leboeuf; Miguel Pais-Vieira
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.